Testing the drug Blinatumomab in children with relapsed leukemia

What we are studying

This study will test whether Blinatumomab plus standard cancer therapy is more effective than standard therapy alone.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 1 - 31

Eligibility Criteria

  • Ask your doctor about eligibility criteria

What is involved

  • Some of your test results will be shared with Children's Oncology Group



Contact Information

Study Coordinator
Graham Keyes

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.